Suppr超能文献

美国对与肝脏相关的死亡率的低估。

Underestimation of liver-related mortality in the United States.

机构信息

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

出版信息

Gastroenterology. 2013 Aug;145(2):375-82.e1-2. doi: 10.1053/j.gastro.2013.04.005. Epub 2013 Apr 9.

Abstract

BACKGROUND & AIMS: According to the National Center for Health Statistics (NCHS), chronic liver disease and cirrhosis is the 12(th) leading cause of death in the United States. However, this single descriptor might not adequately enumerate all deaths from liver disease. The aim of our study was to update data on liver mortality in the United States.

METHODS

Mortality data were obtained from the Rochester Epidemiology Project (1999-2008) and the National Death Registry (1979-2008). Liver-specific mortality values were calculated. In contrast to the narrow NCHS definition, updated liver-related causes of death included other specific liver diagnoses (eg, hepatorenal syndrome), viral hepatitis, and hepatobiliary cancers.

RESULTS

The Rochester Epidemiology Project database contained information on 261 liver-related deaths, with an age- and sex-adjusted death rate of 27.0/100,000 persons (95% confidence interval: 23.7-30.3). Of these, only 71 deaths (27.2%) would have been captured by the NCHS definition. Of cases for which viral hepatitis or hepatobiliary cancer was the cause of death, 96.9% and 94.3% had liver-related immediate causes of death, respectively. In analysis of data from the National Death registry (2008), use of the updated definition increased liver mortality by >2-fold (from 11.7 to 25.7 deaths/100,000, respectively). Using NCHS definitions, liver-related deaths decreased from 18.9/100,000 in 1979 to 11.7/100,000 in 2008-a reduction of 38%. However, using the updated estimate, liver-related deaths were essentially unchanged from 1979 (25.8/100,000) to 2008 (25.7/100,000). Mortality burden was systematically underestimated among non-whites and persons of Hispanic ethnicity.

CONCLUSIONS

Based on analyses of the Rochester Epidemiology Project and National Death databases, liver-related mortality has been underestimated during the past 2 decades in the United States.

摘要

背景与目的

根据国家卫生统计中心(NCHS)的数据,慢性肝脏疾病和肝硬化是美国第 12 大死亡原因。然而,这一单一描述可能无法充分列举所有与肝脏疾病相关的死亡。本研究旨在更新美国肝脏死亡率的数据。

方法

从罗切斯特流行病学项目(1999-2008 年)和国家死亡登记处(1979-2008 年)获得死亡率数据。计算特定于肝脏的死亡率值。与 NCHS 的狭义定义不同,更新后的与肝脏相关的死亡原因包括其他特定的肝脏诊断(如肝肾综合征)、病毒性肝炎和肝胆癌。

结果

罗切斯特流行病学项目数据库包含了 261 例与肝脏相关的死亡信息,年龄和性别调整后的死亡率为 27.0/100,000 人(95%置信区间:23.7-30.3)。其中,只有 71 例(27.2%)符合 NCHS 的定义。在因病毒性肝炎或肝胆癌而死亡的病例中,分别有 96.9%和 94.3%的病例的直接死亡原因为肝脏疾病。在对国家死亡登记处(2008 年)的数据进行分析时,使用更新后的定义使肝脏死亡率增加了两倍以上(分别从 11.7 例/100,000 人增加到 25.7 例/100,000 人)。使用 NCHS 的定义,肝脏相关死亡从 1979 年的 18.9/100,000 人下降到 2008 年的 11.7/100,000 人,减少了 38%。然而,使用更新后的估计值,1979 年与 2008 年(25.8/100,000)的肝脏相关死亡基本保持不变。非白人和西班牙裔美国人的死亡率负担被系统地低估了。

结论

根据罗切斯特流行病学项目和国家死亡数据库的分析,在过去的 20 年中,美国的肝脏相关死亡率被低估了。

相似文献

1
Underestimation of liver-related mortality in the United States.
Gastroenterology. 2013 Aug;145(2):375-82.e1-2. doi: 10.1053/j.gastro.2013.04.005. Epub 2013 Apr 9.
2
4
Causes of death in patients with hepatitis B: a natural history cohort study in the United States.
Hepatology. 2013 Jul;58(1):21-30. doi: 10.1002/hep.26110. Epub 2012 Dec 12.
5
Hepatitis C and hepatitis B-related mortality in Spain.
Eur J Gastroenterol Hepatol. 2009 Aug;21(8):895-901. doi: 10.1097/MEG.0b013e328313139d.
7
Mortality from liver diseases attributable to hepatitis B and C in the EU/EEA - descriptive analysis and estimation of 2015 baseline.
Infect Dis (Lond). 2020 Sep;52(9):625-637. doi: 10.1080/23744235.2020.1766104. Epub 2020 Jun 17.

引用本文的文献

2
Steatotic liver disease is a marker of multimorbidity, not underlying cirrhosis, in older adults.
NPJ Gut Liver. 2025;2(1):10. doi: 10.1038/s44355-025-00024-0. Epub 2025 May 5.
4
Decoding 17-Beta-hydroxysteroid Dehydrogenase 13: A Multifaceted Perspective on Its Role in Hepatic Steatosis and Associated Disorders.
J Clin Transl Hepatol. 2024 Oct 28;12(10):857-864. doi: 10.14218/JCTH.2024.00257. Epub 2024 Sep 19.
5
Diabetes risk reduction diet and risk of liver cancer and chronic liver disease mortality: A prospective cohort study.
J Intern Med. 2024 Nov;296(5):410-421. doi: 10.1111/joim.20007. Epub 2024 Sep 6.
6
Cardiovascular Death and Liver Disease: Mortality Trends and Disparities.
Clin Med Res. 2024 Jun;22(2):57-60. doi: 10.3121/cmr.2024.1842.
7
Hepatoprotective effects of diosmin: a narrative review.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):279-295. doi: 10.1007/s00210-024-03297-z. Epub 2024 Aug 21.
8
Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions.
Nat Rev Gastroenterol Hepatol. 2024 Dec;21(12):834-851. doi: 10.1038/s41575-024-00967-4. Epub 2024 Aug 15.
9
Argonaute-2 autoantibodies: a promising biomarker for predicting mortality in HBV-related acute-on-chronic liver failure patients with cirrhosis.
Front Cell Infect Microbiol. 2024 Jul 25;14:1407064. doi: 10.3389/fcimb.2024.1407064. eCollection 2024.
10
Application of network pharmacology in traditional Chinese medicine for the treatment of digestive system diseases.
Front Pharmacol. 2024 Jul 17;15:1412997. doi: 10.3389/fphar.2024.1412997. eCollection 2024.

本文引用的文献

1
Deaths: leading causes for 2009.
Natl Vital Stat Rep. 2012 Oct 26;61(7):1-94.
2
Chronic hepatitis C virus (HCV) disease burden and cost in the United States.
Hepatology. 2013 Jun;57(6):2164-70. doi: 10.1002/hep.26218. Epub 2013 May 6.
3
Burden of gastrointestinal disease in the United States: 2012 update.
Gastroenterology. 2012 Nov;143(5):1179-1187.e3. doi: 10.1053/j.gastro.2012.08.002. Epub 2012 Aug 8.
4
Epidemiology of viral hepatitis and hepatocellular carcinoma.
Gastroenterology. 2012 May;142(6):1264-1273.e1. doi: 10.1053/j.gastro.2011.12.061.
5
The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.
Ann Intern Med. 2012 Feb 21;156(4):271-8. doi: 10.7326/0003-4819-156-4-201202210-00004.
7
Hepatocellular carcinoma.
N Engl J Med. 2011 Sep 22;365(12):1118-27. doi: 10.1056/NEJMra1001683.
8
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.
Gastroenterology. 2011 Oct;141(4):1249-53. doi: 10.1053/j.gastro.2011.06.061. Epub 2011 Jul 2.
9
Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.
Clin Gastroenterol Hepatol. 2011 Jun;9(6):524-530.e1; quiz e60. doi: 10.1016/j.cgh.2011.03.020. Epub 2011 Mar 25.
10
Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.
Gastroenterology. 2010 Oct;139(4):1246-56, 1256.e1-5. doi: 10.1053/j.gastro.2010.06.019. Epub 2010 Jun 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验